Search for: "Ex Parte Lilly" Results 1 - 20 of 114
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Dec 2012, 7:50 am by Lawrence B. Ebert
Ex parte Borden, 93 USPQ2d 1473, 1474 (BPAI 2010) (informative). [read post]
17 Apr 2013, 6:12 am by Lawrence B. Ebert
Ex parte Taylor Of a rejection for lack of written description, the appellant prevailed: We agree with Appellants. [read post]
15 May 2013, 9:09 am by Lawrence B. Ebert
In Ex parte BOUGHANNAM , appellant won on 102 but lost on 112, with the bottom line, the appellant lost.Of "written description"-->Appellants assert that these claim terms have literal claim support in theSpecification, and thus meet the written description requirement. [read post]
10 Apr 2008, 3:08 am
In Ex Parte Bilski, an en banc Federal Circuit plans to reconsider the scope of patentable subject matter as it relates to business methods and so called mental methods. [read post]
21 Mar 2013, 10:11 am by Lawrence B. Ebert
The bottom line in Ex parte Barber:The Examiner did not err in rejecting claims 1, 3-7, 9-21, 23-41, 63-68, 70, and 71 under 35 U.S.C. [read post]
16 Jan 2013, 8:46 am by Lawrence B. Ebert
Eli Lilly and Co., 598 F.3d 1336, 1351 (Fed. [read post]
30 Mar 2010, 3:33 am by Dennis Crouch
In my recent essay, I wrote that – apart from its value in "new matter" rejections – the role of the written description requirement in ex parte prosecution is negligible. [read post]
7 Oct 2013, 6:02 am by Lawrence B. Ebert
Ex parte BrownWhether a specification complies with the written description requirement of 35 U.S.C. [read post]
17 Jan 2013, 2:15 pm by Lawrence B. Ebert
Within Ex parte Smalleyas to anticipationThe removal of Hoy’s strips 58, 60 creates a first opening capable of article removal when utilized with articles of appropriately configured sizes and shapes. [read post]
15 Feb 2010, 12:00 pm by Dennis Crouch
Ex parte Pfizer (BPAI 2010) Pfizer's broadest patent covering its bestselling drug Viagra is in the midst of an ex parte reexamination. [read post]
20 Nov 2013, 9:35 pm by Aaron Barkoff
BioDelivery filed its petition for inter partes review on June 12, 2013, more than one year after MonoSol served BioDelivery with a complaint asserting infringement of the '292 patent, but less than one year after an ex parte reexamination proceeding terminated upon issuance of a reexamination certificate that confirmed or amended each of the original claims. [read post]
8 Nov 2007, 9:50 am
The USPTO has released the list of organizations and persons that submitted comments in response to the July 2007 Rules of Practice Before the Board of Patent Appeals and Interferences in Ex Parte Appeals, Notice of Proposed Rule Making, first published in the Federal Register at 72 Fed. [read post]
12 Mar 2013, 5:43 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1340 (Fed. [read post]
18 Jan 2013, 7:28 am by Lawrence B. Ebert
from Ex part SHEPHERDOf written description:Ariad Pharms., Inc. v. [read post]
20 Jul 2020, 11:20 am by Miquel Montañá (Clifford Chance)
As you perfectly know the patent courts of Barcelona resolve an ex parte PI application in about 14 days, thus a 30 day notice is fully respectful of your client’s rights. [read post]